Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-10-17, Stock:JNJ, The news for the past five days is as follows:
2019-10-10: NEWS1: J&J (JNJ) to Start Q3 Earnings Season for Pharma Sector.NEWS2: Company News For Oct 10, 2019.
2019-10-11: NEWS1: Why Johnson & Johnson Stock Can Weather Legal Awards Against It.NEWS2: What to Expect from Q3 Earnings Season with Big Banks Set to Report?.NEWS3: J&J CEO touts Philadelphia's potential to be the 'Silicon Valley of health care'.NEWS4: Johnson & Johnson Stock Has Limited Upside.NEWS5: Pharma Stock Roundup: NVS' New Eye Drug Gets FDA Nod, NVO, GSK, PFE Sign Deals.NEWS6: Will Q3 Earnings Drive Dow ETF Higher?.NEWS7: J&J Rises After Analyst Calls Pharma Giant's Shares a Bargain.NEWS8: Geron Starts Enrollment in Phase III MDS Study on Imetelstat.NEWS9: The Daily Biotech Pulse: Therapix Extends Merger Deadline, Five Prime Restructures, Gilead-Galapagos Rheumatism Drug Readout.
2019-10-14: NEWS1: Johnson & Johnson's (JNJ) Legal Problems Continue to Worry Investors.NEWS2: Dow Jones Futures: Tesla Reclaims Key Support; These 4 Dow Stocks Report Early Tuesday.NEWS3: J&J is swamped by opioid fears and lawsuits, but Wall Street isn't worried.NEWS4: Bank earnings — What to know in markets Tuesday.NEWS5: The Zacks Analyst Blog Highlights: Novartis, J&J, Pfizer, Novo Nordisk and Glaxo.NEWS6: Major Banks To Flood Wall Street with Earnings Data.NEWS7: Bank Holiday Ahead of Q3 Earnings, Trade Negotiations.NEWS8: Johnson & Johnson Is Reporting Its Earnings on Tuesday. Here’s What To Expect..
2019-10-15: NEWS1: Dow Jones Futures: 5 Big Movers Late; Stock Market Leader ASML On Tap With Earnings.NEWS2: US Indexes Close Higher Tuesday With 3rd-Quarter Earnings Kickoff.NEWS3: Oklahoma judge says he miscalculated award in J&J opioid case by $107 million.NEWS4: Wall Street Advances Tuesday.NEWS5: J&J Says No Legal Reserves Needed Amid Wave of Lawsuits.NEWS6: Drug Distributors Could Be Nearing An $18 Billion Opioid Settlement.NEWS7: Drug distributors in talks to settle opioid litigation for $18 bln - WSJ.NEWS8: Pharma Giant J&J Reports Rising Earnings, Sales — And Legal Fees.NEWS9: UPDATE 1-Missouri appeals court overturns $110 mln Johnson & Johnson talc verdict.NEWS10: JNJ, JP Morgan and UnitedHealth all Beat, Goldman Sachs Misses.NEWS11: Missouri appeals court overturns $110 million Johnson & Johnson talc verdict.NEWS12: PreMarket Prep Recap: Impressive Bank Earnings, Aphria Sparks Rally In Marijuana Sector.NEWS13: Jim Cramer: Here's What We Can Bask in Today.NEWS14: Johnson & Johnson (JNJ) Surpasses Q3 Earnings and Revenue Estimates.NEWS15: US STOCKS-Wall Street advances as earnings season hits the road running.NEWS16: Johnson & Johnson on mushrooming lawsuits: 'We're targets, unfortunately'.NEWS17: US STOCKS-Wall Street gains after strong start to earnings season.NEWS18: What Investors Need to Know About Johnson & Johnson's 3rd-Quarter Results.NEWS19: Johnson & Johnson Is Facing Mounting Legal Fees — Is JNJ Stock A Safe Buy?.NEWS20: Johnson & Johnson Stock Is Up After Its Earnings Beat.NEWS21: The Dow Is Up Because Strong Earnings Can Make Us Forget About Trade.NEWS22: Pharma Giant J&J Reports Rising Earnings, Sales — And Legal Fees.NEWS23: J&J (JNJ) Gets FDA Approval for Xarelto Label Expansion.NEWS24: J&J (JNJ) Beats on Q3 Earnings as Sales Rise, Ups 2019 View.NEWS25: Prescription drugs boost drives J&J forecasts higher, shares rise.NEWS26: Pharma Giant J&J Reports Rising Earnings, Sales — And Legal Fees.NEWS27: Q3 Results Begin: Can We Avoid an Earnings Recession?.NEWS28: Dow up 280 points on gains for UnitedHealth, JPMorgan Chase stocks.NEWS29: Initial Q3 Results Are Better-Than-Expected.NEWS30: For J&J and UnitedHealth, Making Money's Easy for Now.NEWS31: US STOCKS-Wall St rises after upbeat start to earnings season.NEWS32: Bank Earnings Quartet Mostly In Tune, Led By Strength At JPMorgan, Citigroup.NEWS33: Relmada Shares Hit 4-Year High As Depression Drug Aces Midstage Trial.NEWS34: US STOCKS-Wall St headed higher on strong earnings start.NEWS35: UnitedHealth, J.P. Morgan Chase, Johnson & Johnson earnings beats adding combined 119 points to the Dow.NEWS36: UnitedHealth, Johnson & Johnson share gains lead Dow's 135-point climb.NEWS37: For ESG investors, the newest challenge is separating fact from ‘greenwashing’.NEWS38: The Dow Is Rising as Fed Policy, Earnings and Brexit Push Trade Aside.NEWS39: Here's Why You Should Hold on to CONMED (CNMD) Stock for Now.NEWS40: J&J (JNJ) Beats Q3 Earnings & Sales, Shares Rise.NEWS41: Prescription drugs boost drives J&J forecasts higher, shares rise.NEWS42: Johnson & Johnson Trades Higher On Q3 Beat-And-Raise, Despite Legal Entanglements.NEWS43: Dow Jones Futures: Snoozing Stock Market Gets Jolt As 4 Dow Giants Report.NEWS44: J&J boosts full-year outlook but warns of uncertain legal costs.NEWS45: UPDATE 2-Prescription drugs boost drives J&J forecasts higher, shares rise.NEWS46: Johnson & Johnson Earnings, Sales Unexpectedly Rise; JNJ Stock Climbs.NEWS47: Johnson & Johnson shares rise after earnings beat estimates, company raises guidance.NEWS48: Prescription drugs boost drives J&J forecasts higher, shares rise.NEWS49: Johnson & Johnson Reports 2019 Third-Quarter Results.NEWS50: [video]Stocks Rise as Earnings From JPMorgan Chase and UnitedHealth Boost Dow.NEWS51: Johnson & Johnson to Host Earnings Call.NEWS52: Johnson & Johnson Tops Q3 Profit Forecast, Lifts 2019 Guidance: Pharma Surprises.NEWS53: J&J Earnings, Revenue Beat in Q3.
2019-10-16: NEWS1: Johnson & Johnson Stock Rebounds After Earnings.NEWS2: Johnson & Johnson's 3 Most Profitable Lines of Business (JNJ).NEWS3: PreMarket Prep Recap: Stormy Outlook For Cloud Stocks, Opioid Makers Rally On Settlement Talks.NEWS4: Stock market news: October 16, 2019.NEWS5: Large Option Traders Aren't Buying The Johnson & Johnson Rally.NEWS6: Analysts, Investors Like Johnson & Johnson's Improvement, But Lawsuits Loom.NEWS7: Dow Gets A Boost From These 3 Key Stocks, But Software Thumps Nasdaq.NEWS8: Dow Gets A Boost From This Big Stock, But Software Thumps Nasdaq.NEWS9: St. Louis court tosses $110M talc verdict against Johnson & Johnson.NEWS10: 'High-level dope dealers': Democratic candidates sound off on big pharma.NEWS11: Opioid Drug Companies Rally On Hopes of Broader Settlement.NEWS12: McKesson, Cardinal Health, AmerisourceBergen stocks surge after WSJ report of $18 billion settlement talks.NEWS13: Dow flat in spite of gains in Johnson & Johnson, Dow Inc. shares.NEWS14: J&J Makes $4 Billion Opioid Offer as Distributors Seek Deal.NEWS15: JNJ Beats, Ups View: Healthcare ETFs to Buy.NEWS16: Stock Market News for Oct 16, 2019.NEWS17: Cardinal Health Stock, Other Drug Distributors, Jump on Possible Opioid Settlement.NEWS18: The S&P 500 may be ‘one decent day of gains’ away from a ‘breakout’.NEWS19: Dow Jones Futures: Chip Leader ASML Leads Key Movers As Stock Market Rally Steps Up.NEWS20: Market Morning: Brexit Back’n’Forth, Carrie Lam Booed Off Stage, Buffett Wants BofA, Balkman Blunders.NEWS21: Dow Jones Futures: After Bullish Stock Market Rally; Chip Leader ASML Leads Key Movers.NEWS22: Johnson & Johnson Gains On Opioid Settlement Reports; Distribution Firms Surge.NEWS23: Opening Quote: Asos FY profits fall by two-thirds.NEWS24: Dow Jones Futures: China Tensions Rise Over Hong Kong After Bullish Stock Market Rally; ASML On Tap.NEWS25: UPDATE 3-Three drug distributors in talks to settle opioid litigation for $18 bln -WSJ.

Answer: Rise